Waldman Reid Alexander
Waldman Reid Alexander, CEO, reported an open-market or private sale at Veradermics, Inc involving 27490.000000 shares for an estimated $2981290.50. Reported holdings after the transaction were 174073.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Aug 17, 2026
- Filing date
- Aug 19, 2026
How reported position traded is calculated
Shares sold ÷ (holdings after + shares sold). Estimated position before: 201,563 shares.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
MANE price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- Sell Code S
- Identifier
- 0001628280-26-057813 Common Stock
- Transaction date
- Aug 17, 2026 Filed Aug 19, 2026, 01:04 AM · 2d delay
- Shares
- 27,490 sh $108.45 per share
- Estimated value
- -$2.98M Computed from shares × price
- Holdings after
- 174,073 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
+10 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 2
Filing reported within two business days of the transaction.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Chief Executive Officer
- F1
The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $106.07 to $107.00, inclusive. The Reporting Person undertakes to provide to the Issuer, an…
- F2
The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $107.00 to $108.00, inclusive. The Reporting Person undertakes to provide to the Issuer, an…
- F3
The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $108.00 to $108.99, inclusive. The Reporting Person undertakes to provide to the Issuer, an…
- F4
The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $109.02 to $109.84, inclusive. The Reporting Person undertakes to provide to the Issuer, an…
- F5
This option is fully vested and exercisable as of the date hereof.
0 other transactions
0 recent txs